J Bi, V Garg, AR Yates - Biomolecules, 2021 - mdpi.com
Extracorporeal life support provides perfusion for patients with heart failure to allow time for recovery, function as a bridge for patients to heart transplantation, or serve as destination …
C McGinn, FA Casey, C Watson… - Cardiology in the …, 2023 - cambridge.org
Introduction: Paediatric heart failure is a common clinical syndrome that may be experienced by children with congenital heart disease (CHD) and/or cardiomyopathy. It is characterised …
R Ragusa, A Di Molfetta, A Amodeo, MG Trivella… - Clinica Chimica …, 2020 - Elsevier
Heart Failure (HF) is a progressive clinical syndrome characterized by molecular and structural abnormalities that result in impaired ventricular filling and a reduced blood …
Y Ma, L Guo, J Ying, Y Xu - Journal of Pharmaceutical Innovation, 2023 - Springer
Introduction Pediatric heart failure imposes a significant health burden, necessitating effective interventions. Left ventricular assist devices (VADs) have emerged as crucial tools …
Introduction: The suppression of tumorigenicity 2 (ST2) is a receptor member belonging to the interleukin-1 (IL-1) family. The ligand and soluble versions are its two isoforms. The IL-33 …
R Ragusa, A Di Molfetta, A Mercatanti, L Pitto… - JHLT open, 2024 - Elsevier
Background Ventricular assist device (VAD) implant represents a therapeutic option for pediatric patients with end-stage heart failure (HF). Heart unloading by VAD can modify …
АУ Хамадьянова, АР Валинуров… - Комплексные …, 2023 - nii-kpssz.com
Аннотация Сердечная недостаточность (СН) у детей может развиваться по разным причинам, которые зависят от возраста. Например, в период новорожденности и в …
J Bi, V Garg, AR Yates - Molecular Biomarkers In Cardiology, 2021 - mdpi.com
Extracorporeal life support provides perfusion for patients with heart failure to allow time for recovery, function as a bridge for patients to heart transplantation, or serve as destination …